These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

1353 related items for PubMed ID: 28060739

  • 1. A novel microRNAs expression signature for hepatocellular carcinoma diagnosis and prognosis.
    Lu M, Kong X, Wang H, Huang G, Ye C, He Z.
    Oncotarget; 2017 Jan 31; 8(5):8775-8784. PubMed ID: 28060739
    [Abstract] [Full Text] [Related]

  • 2. Hepatocellular carcinoma associated microRNA expression signature: integrated bioinformatics analysis, experimental validation and clinical significance.
    Shi KQ, Lin Z, Chen XJ, Song M, Wang YQ, Cai YJ, Yang NB, Zheng MH, Dong JZ, Zhang L, Chen YP.
    Oncotarget; 2015 Sep 22; 6(28):25093-108. PubMed ID: 26231037
    [Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8. Bioinformatics Analyses of Potential miRNA-mRNA Regulatory Axis in HBV-related Hepatocellular Carcinoma.
    Huang DP, Zeng YH, Yuan WQ, Huang XF, Chen SQ, Wang MY, Qiu YJ, Tong GD.
    Int J Med Sci; 2021 Sep 22; 18(2):335-346. PubMed ID: 33390802
    [Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10. A P53-related microRNA model for predicting the prognosis of hepatocellular carcinoma patients.
    Fang SS, Guo JC, Zhang JH, Liu JN, Hong S, Yu B, Gao Y, Hu SP, Liu HZ, Sun L, Zhao Y.
    J Cell Physiol; 2020 Apr 22; 235(4):3569-3578. PubMed ID: 31556110
    [Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12. [Bioinformatics on vascular invasion markers in hepatocellular carcinoma via Big-Data analysis].
    Chen Q, Qiu XQ.
    Zhonghua Liu Xing Bing Xue Za Zhi; 2017 Apr 10; 38(4):522-527. PubMed ID: 28468075
    [Abstract] [Full Text] [Related]

  • 13. Identification of a five-long non-coding RNA signature to improve the prognosis prediction for patients with hepatocellular carcinoma.
    Zhao QJ, Zhang J, Xu L, Liu FF.
    World J Gastroenterol; 2018 Aug 14; 24(30):3426-3439. PubMed ID: 30122881
    [Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16. A five-miRNA expression signature predicts survival in hepatocellular carcinoma.
    Liu G, Wang H, Fu JD, Liu JY, Yan AG, Guan YY.
    APMIS; 2017 Jul 14; 125(7):614-622. PubMed ID: 28430373
    [Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19. Circulating miRNA-199a and miRNA-122 Levels as Potential Diagnostic and Prognostic Biomarkers for Hepatocellular Carcinoma.
    Wu J, Wu Y, Luo Y, Li X, Lin N, Yang X, Lin Y, Chen M.
    Ann Clin Lab Sci; 2020 Mar 14; 50(2):219-227. PubMed ID: 32366560
    [Abstract] [Full Text] [Related]

  • 20. MicroRNA profile in HBV-induced infection and hepatocellular carcinoma.
    Wang G, Dong F, Xu Z, Sharma S, Hu X, Chen D, Zhang L, Zhang J, Dong Q.
    BMC Cancer; 2017 Dec 01; 17(1):805. PubMed ID: 29191172
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 68.